• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Integra LifeSciences

Integra LifeSciences posts earnings beat in Q4

February 18, 2021 By Sean Whooley Leave a Comment

Integra LifeSciences (NSDQ:IART) shares dipped today despite fourth-quarter results that beat the consensus earnings forecast. The Princeton, N.J.-based medtech company posted profits of $92.7 million, or $1.09 per share, on sales of $388.6 million for the three months ended Dec. 31, 2020, coming in well ahead of its Q4 2019 profit of $15.3 million despite a […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: coronavirus, COVID-19, Integra LifeSciences

Smith + Nephew closes Extremity Orthopedics purchase

January 4, 2021 By Sean Whooley

Integra LifeSciences (NSDQ:IART) announced today that it completed the divestiture of its extremity orthopedics business to Smith+Nephew (NYSE:SNN). The companies previously announced the planned divestiture, worth $240 million, in September 2020. At the time, London-based Smith+Nephew said that the acquisition would significantly strengthen its extremities business by adding a combination of a focused sales channel and complimentary […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Orthopedics Tagged With: Integra LifeSciences, Smith+Nephew

Integra LifeSciences to acquire ACell

December 16, 2020 By Danielle Kirsh

Integra LifeSciences (NSDQ:IART) today said it entered into a definitive agreement to acquire ACell. Through the deal, Integra LifeSciences will pay $300 million in cash upfront at closing, subject to customary purchase price adjustments with cash payments of up to an additional $100 million upon certain revenue growth milestones. Columbia, Md.-based ACell currently develops The MatriStem […]

Filed Under: Mergers & Acquisitions Tagged With: ACell, Integra LifeSciences

Smith+Nephew to buy Integra extremities business for $240M

September 29, 2020 By Sean Whooley

Smith+Nephew (NYSE:SNN) announced today that it agreed to acquire the extremity orthopedics business from Integra LifeSciences (NSDQ:IART) for $240 million. London-based Smith+Nephew said in a news release that the acquisition will significantly strengthen its extremities business by adding a combination of a focused sales channel and complimentary shoulder replacement and upper and lower extremities portfolios, plus a […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Orthopedics Tagged With: Integra LifeSciences, Smith & Nephew, Smith+Nephew

Integra ticks up on Street-beating Q2

August 11, 2020 By Sean Whooley

Integra LifeSciences (NSDQ:IART) shares got a boost today on second-quarter results that came in ahead of the consensus forecast. The Princeton, N.J.-based medtech company posted losses of -$369,000, or $0.00 per share, on sales of $258.7 million for the three months ended June 30, 2020, for a bottom-line slide into the red on a sales decline […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: coronavirus, COVID-19, Integra LifeSciences

Integra touts outcomes, cost-savings in wound-healing studies

May 18, 2020 By Nancy Crotti

A pair of retrospective studies of an Integra LifeSciences (NSDQ:IART) wound-healing matrix showed positive clinical and economic results, the company announced on Friday. The studies looked at the results of complex lower extremity reconstruction using Integra’s bilayer wound matrix. The data were published in Plastic and Reconstructive Surgery. The bilayer wound-healing matrix is formulated to provide […]

Filed Under: Clinical Trials, Featured, Hospital Care, Surgical, Wound Care Tagged With: Integra LifeSciences, University of Pennsylvania

Integra LifeSciences up despite missing on Q1 projections

May 7, 2020 By Sean Whooley

Integra LifeSciences (NSDQ:IART) shares ticked up today despite first-quarter results that came up short of the consensus forecast. The Princeton, N.J.-based company posted profits of $9.2 million, or 11¢ per share, on sales of $354.3 million for the three months ended March 31, 2020, for a -71.9% bottom-line slide on a sales decline of -1.5%. Adjusted […]

Filed Under: Business/Financial News, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Integra LifeSciences

Integra warns on NeuraGen Nerve Guide

March 5, 2020 By Sean Whooley

Integra LifeSciences (NSDQ:IART) issued an urgent field safety notice to warn of an issue with the 7 mm NeuraGen Nerve Guide due to one specific lot of parts that failed to meet release criteria. The NeuraGen Nerve Guide, part number PNG720, had one lot released that was out of specification for a finished goods release test. […]

Filed Under: Neurological, Recalls, Regulatory/Compliance Tagged With: Integra LifeSciences

Integra shares up on raised guidance, Street-beating earnings

February 19, 2020 By Sean Whooley

Integra LifeSciences (NSDQ:IART) shares ticked up today on fourth-quarter results that revealed mixed results when compared to the consensus forecast but resulted in raised guidance for fiscal 2020. The Plainsboro, N.J.-based surgical devices company posted profits of $15.3 million, or 18¢ per share, on sales of $395.1 million for the three months ended Dec. 31, 2019, […]

Filed Under: Business/Financial News, Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Integra LifeSciences

Integra LifeSciences ticks up on Q3 beats

October 25, 2019 By Brad Perriello

Integra LifeSciences (NSDQ:IART) shares ticked up in pre-market trading today after the medical device company reported third-quarter numbers that topped estimates. Plainsboro, N.J.-based Integra posted losses of -27.6 million, or -32¢ per share, on sales of $379.1 million for the three months ended Sept. 30, marking a swing to red ink on sales growth of […]

Filed Under: Featured, MassDevice Earnings Roundup, Wall Street Beat Tagged With: Integra LifeSciences

Integra Lifesciences touts Cadence ankle study

September 20, 2019 By Sean Whooley

Integra LifeSciences (NSDQ:IART) yesterday touted positive findings from its Cadence total ankle system retrospective study and closed enrollment ahead of schedule for two post-market studies of the device. The study reported that patients treated with Cadence while suffering from end-stage arthritis experienced improvements in quality of life, functional measures and pain. The results were presented during […]

Filed Under: Clinical Trials, Orthopedics, Surgical Tagged With: Extremities, Integra LifeSciences

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 10
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS